Clinigen patents expiration
1. Ethyol patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5591731 | CLINIGEN | Crystalline amifostine compositions |
Jul, 2012
(11 years ago) | |
| US5424471 | CLINIGEN | Crystalline amifostine compositions and methods of the preparation and use of same |
Jul, 2012
(11 years ago) | |
| US5994409 | CLINIGEN | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
Dec, 2017
(6 years ago) | |
Drugs and Companies using AMIFOSTINE ingredient
Market Authorisation Date: 10 September, 1999
Treatment: Methods for using the drug product
Dosage: INJECTABLE;INJECTION
How can I launch a generic of ETHYOL before it's drug patent expiration?
More Information on Dosage
ETHYOL family patents
2. Totect patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6727253 | CLINIGEN | Treatment of accidental extravasation of anthracyclines |
Mar, 2020
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Sep 06, 2014 |
Drugs and Companies using DEXRAZOXANE HYDROCHLORIDE ingredient
Market Authorisation Date: 06 September, 2007
Treatment: Treatment of extravasation resulting from iv anthracycline chemotherapy
Dosage: INJECTABLE;INJECTION
More Information on Dosage
TOTECT family patents